Use of gadolinium for MRI diagnostic or surveillance studies in patients with MS.

@article{Haider2019UseOG,
  title={Use of gadolinium for MRI diagnostic or surveillance studies in patients with MS.},
  author={Lukas Haider and Robert T. Naismith and Alex Rovira},
  journal={Neurology},
  year={2019}
}
Brain MRI scans using gadolinium-based contrast agents (GBCAs) have played a central role in diagnosing and monitoring patients with multiple sclerosis (MS).1 GBCAs were initially considered extremely safe.2 Measurable GBCA tissue accumulation has been demonstrated in the dentate nucleus and other CNS structures as increased signal intensity on unenhanced T1-weighted images.3 Due to the potential toxicity of free gadolinium, these reports have raised concern within the scientific community, and… CONTINUE READING

Topics from this paper.